India Glycols Limited (INDIAGLYCO) — Board Meeting | 21 August 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Board sets effective and record dates for scheme of arrangement
💡 Investor Takeaway
Shareholders will receive new shares in the demerged entities based on defined exchange ratios, with the transaction effective in early September 2026.

India Glycols announced that its board fixed September 1, 2026 as the effective date and September 2, 2026 as the record date for the scheme of arrangement involving demerger into Ennature Bio Pharma and IGL Spirits. Shareholders will receive one share of each resulting company per specified holding ratios, with shares to be listed on NSE and BSE after regulatory approvals.

📄 View Original Announcement (PDF)

About India Glycols Limited (INDIAGLYCO)

Fast Moving Consumer Goods · Alcoholic Beverages · Listed on NSE

Market Cap: ₹7,459.41 Cr P/E: 22.5 ROE: 10.8% ROCE: 12.3% Div Yield: 0.67%

View full INDIAGLYCO stock details →

📡 Get AI alerts when INDIAGLYCO files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track INDIAGLYCO — Free

📊 More INDIAGLYCO filings

See all INDIAGLYCO filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when INDIAGLYCO files new disclosures

Track INDIAGLYCO filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track INDIAGLYCO — Free

Free account · 2 AI queries/day